The Official Medicare Set Aside Blog And Information Resource

FDA Issues Draft Guidance on Clinical Research with Cannabis and Cannabis-Derived Compounds

FDA, Medical Cannabis, Medicare Set-Aside Blog on July 28, 2020
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

Medical cannabis continues to create a host of questions as related to workers’ compensation claims, including the legality of use, particularly as guidance and policies continue to be issued.  On July 21st, the FDA issued draft guidance for clinical research with cannabis and cannabis-derived compounds. The guidance does not apply to fully synthetic versions of cannabis, which […] Continue